Amilyfe, LLC

11 patents currently held · Updated Nov 15, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Entrinsic, LLC (to 2024)

Ending by 2030

Nov 2035

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Jul 23, 2027
The maintenance fee for Generation of Hydration-Targeted Formulations and Methods of Use Therein (US 11,878,073) comes due Jul 23, 2027. Unpaid by Jan 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Patent	Title	Status	Expires	Confidence
US 10,758,506	Amino acid compositions for the treatment of porcine epidemic diarrhea In force Term ends Nov 19, 2035 · From the USPTO record	In force	Term ends Nov 19, 2035	From the USPTO record
US 11,357,747	Amino acid compositions for the amelioration of symptoms of hangover In force Term ends Nov 19, 2035 · From the USPTO record	In force	Term ends Nov 19, 2035	From the USPTO record
US 12,161,614	Amino acid compositions for the amelioration of symptoms of environmental enteropathy In force Term ends Nov 9, 2036 · From the USPTO record	In force	Term ends Nov 9, 2036	From the USPTO record
US 11,576,884	Amino Acid Compositions and Uses Thereof In force Term ends Nov 7, 2039 · High confidence	In force	Term ends Nov 7, 2039	High confidence
US 12,109,191	Materials and Methods for Inhibiting Tumor Growth In force Term ends Mar 25, 2041 · High confidence	In force	Term ends Mar 25, 2041	High confidence
US 12,357,600	Formulations for promoting hydration and methods of use thereof In force Term ends Jul 1, 2041 · From the USPTO record	In force	Term ends Jul 1, 2041	From the USPTO record
US 12,220,400	Amino acid compositions and methods for treating cystic fibrosis In force Term ends Apr 6, 2042 · From the USPTO record	In force	Term ends Apr 6, 2042	From the USPTO record
US 11,878,073	Generation of Hydration-Targeted Formulations and Methods of Use Therein In force Term ends Sep 20, 2042 · High confidence	In force	Term ends Sep 20, 2042	High confidence
US 12,239,681	Formulations and Methods for Skin Care In force Term ends Dec 30, 2042 · Medium confidence	In force	Term ends Dec 30, 2042	Medium confidence
US 12,274,729	Formulations and Methods for Skin Care or Hyaluronic Acid Synthesis In force Term ends Dec 30, 2042 · Low confidence	In force	Term ends Dec 30, 2042	Low confidence

10 of 11 patents shown.

Pro members see all 11.

Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 1 no status recorded

List them